Medicine
Mepivacaine 300 mg/30 mL injection
Mepivacaine 300 mg/30 mL injection is a generic prescription medicine for epidural, infiltration use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), brief exposure up to 40 °C (104 °F) does…
Key facts
- Active ingredient (INN)
- Mepivacaine
- Brand
- Sold under the generic name
- Strength
- 300 mg/30 mL
- Dosage form
- Injection
- Route
- Epidural, infiltration
- Packs
- 30 mL, 25 pouches of 30 mL
- Manufacturer
- HealthFirst
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), brief exposure up to 40 °C (104 °F) does not adversely affect the product.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01BB03 Mepivacaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 December 2019
- Identifiers
- RxCUI 1866503DailyMed set ID 996381e2-485b-9434-e053-2a95a90a08e1NDC 51662-1403Application ANDA089406
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 mL in 1 vial, single-dose | 51662-1403-1 | HealthFirst | 10 December 2019 |
| 25 pouch in 1 case / 1 vial, single-dose in 1 pouch / 30 mL in 1 vial, single-dose | 51662-1403-3 | HealthFirst | 8 January 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 January 1960 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Mepivacaine 300 mg/30 mL injection.
Other strengths and forms of Mepivacaine
Clinical summary
Mepivacaine is an amide local anesthetic indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. It is available as injection for submucosal, infiltration and epidural use. MedsAcross supplies Mepivacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MepivacaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Scandonest 3% Plain prescribing information (Septodont) · U.S. National Library of Medicine, DailyMed
Need Mepivacaine 300 mg/30 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.